- Namita Roy-Chowdhury, PhD
Namita Roy-Chowdhury, PhD
- Professor of Medicine and Genetics
- Albert Einstein College of Medicine
- Jayanta Roy-Chowdhury, MD, MRCP
Jayanta Roy-Chowdhury, MD, MRCP
- Professor of Medicine and Genetics
- Albert Einstein College of Medicine
- Section Editors
- Elizabeth B Rand, MD
Elizabeth B Rand, MD
- Section Editor — Pediatric Hepatology
- Professor of Pediatrics
- University of Pennsylvania School of Medicine
- Keith D Lindor, MD
Keith D Lindor, MD
- Section Editor — Alcoholic and Metabolic Liver Disease
- Professor of Medicine, Mayo Clinic College of Medicine
- Dean, College of Health Solutions
- Arizona State University
●Uptake from the circulation
●Conjugation with glucuronic acid
●Biliary excretionTo continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- CRIGLER JF Jr, NAJJAR VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 1952; 10:169.
- CHILDS B, SIDBURY JB, MIGEON CJ. Glucuronic acid conjugation by patients with familial nonhemolytic jaundice and their relatives. Pediatrics 1959; 23:903.
- SZABO L, EBREY P. STUDIES ON THE INHERITANCE OF CRIGLER--NAJJAR'S SYNDROME BY THE MENTHOL TEST. Acta Paediatr Acad Sci Hung 1963; 4:153.
- Kadakol A, Ghosh SS, Sappal BS, et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 2000; 16:297.
- Maruo Y, Verma IC, Matsui K, et al. Conformational change of UGT1A1 by a novel missense mutation (p.L131P) causing Crigler-Najjar syndrome type I. J Pediatr Gastroenterol Nutr 2008; 46:308.
- Sneitz N, Bakker CT, de Knegt RJ, et al. Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat 2010; 31:52.
- Seppen J, Bosma PJ, Goldhoorn BG, et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 1994; 94:2385.
- Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333:1171.
- Bosma PJ, Seppen J, Goldhoorn B, et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994; 269:17960.
- Jansen PL, Bosma PJ, Roy Chowdhury J. Molecular Biology of Bilirubin metabolism. In: Progress Liver Diseases, Boyer JL, Ockner RK (Eds), WB Saunders, Philadelphia 1995. Vol XIII, p.125.
- Erps LT, Ritter JK, Hersh JH, et al. Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest 1994; 93:564.
- Chalasani N, Chowdhury NR, Chowdhury JR, Boyer TD. Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology 1997; 112:2099.
- Kadakol A, Sappal BS, Ghosh SS, et al. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet 2001; 38:244.
- Gunn CH. Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 1938; 29:137.
- Roy Chowdhury J, Van Es HH, Roy Chowdhury N, Gunn rat. An animal model of deficiency of bilirubin conjugation. In: Hepatic Transport and Bile Secretion, Physiology and Pathophysiology, Tavoloni N, Berk PD (Eds), Raven, New York 1992. p.713.
- SCHMID R, AXELROD J, HAMMAKER L, SWARM RL. Congenital jaundice in rats, due to a defect in glucuronide formation. J Clin Invest 1958; 37:1123.
- Blaschke TF, Berk PD, Scharschmidt BF, et al. Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen. Pediatr Res 1974; 8:573.
- Sleisenger MH. Nonhemolytic unconjugated hyperbilirubinemia with hepatic glucuronyl transferase deficiency: a genetic study in four generations. Trans Assoc Am Physicians 1967; 80:259.
- Arias IM, Gartner LM, Cohen M, et al. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med 1969; 47:395.
- Berk PD, Martin JF, Blaschke TF, et al. Unconjugated hyperbilirubinemia. Physiologic evaluation and experimental approaches to therapy. Ann Intern Med 1975; 82:552.
- Kapitulnik J, Kaufmann NA, Goitein K, et al. A pigment found in Crigler--Najjar syndrome and its similarity to an ultrafiltrable photoderivative of bilirubin. Clin Chim Acta 1974; 57:231.
- Moscowitz A, Weimer M, Lightner DA, et al. The in vitro conversion of bile pigments to the urobilinoids by a rat clostridia species as compared with the human fecal flora. 3. Natural d-urobilin, synthetic i-urobilin, and synthetic i-urobilinogen. Biochem Med 1970; 4:149.
- BILLING BH, GRAY CH, KULCZYCKA A, et al. THE METABOLISM OF (14C)-BILIRUBIN IN CONGENITAL NON-HAEMOLYTIC HYPERBILIRUBINAEMIA. Clin Sci 1964; 27:163.
- NOVIKOFF AB, ESSNER E. The liver cell. Some new approaches to its study. Am J Med 1960; 29:102.
- Maisels MJ. Neonatal jaundice. Semin Liver Dis 1988; 8:148.
- Maruo Y, Nishizawa K, Sato H, et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999; 103:1224.
- Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics 1986; 78:837.
- Grunebaum E, Amir J, Merlob P, et al. Breast mild jaundice: natural history, familial incidence and late neurodevelopmental outcome of the infant. Eur J Pediatr 1991; 150:267.
- Kadakol A, Deocharan B, Mukhopadhyay L, et al. Rapid prenatal diagnosis of Crigler-Najjar syndrome type 1 by genetic analysis of chorionic villus samples (abstract). Hepatology 1998; 28:316A.
- Wolkoff AW, Chowdhury JR, Gartner LA, et al. Clinical conference. Crigler-Najjar syndrome (type I) in an adult male. Gastroenterology 1979; 76:840.
- BERENDSOHN S, LOWMAN J, SUNDBERG D, WATSON CJ. IDIOPATHIC DYSERYTHROPOIETIC JAUNDICE. Blood 1964; 24:1.
- van der Veere CN, Sinaasappel M, McDonagh AF, et al. Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology 1996; 24:311.
- Sokal EM, Silva ES, Hermans D, et al. Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Transplantation 1995; 60:1095.
- Itoh S, Onishi S. Kinetic study of the photochemical changes of (ZZ)-bilirubin IX alpha bound to human serum albumin. Demonstration of (EZ)-bilirubin IX alpha as an intermediate in photochemical changes from (ZZ)-bilirubin IX alpha to (EZ)-cyclobilirubin IX alpha. Biochem J 1985; 226:251.
- Pett S, Mowat AP. Crigler-Najjar syndrome types I and II. Clinical experience--King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation. Mol Aspects Med 1987; 9:473.
- Lund HT, Jacobsen J. Influence of phototherapy on the biliary bilirubin excretion pattern in newborn infants with hyperbilirubinemia. J Pediatr 1974; 85:262.
- Gajdos V, Petit F, Trioche P, et al. Successful pregnancy in a Crigler-Najjar type I patient treated by phototherapy and semimonthly albumin infusions. Gastroenterology 2006; 131:921.
- Ahmed P, Pratt A, Land VJ, et al. Multiple plasma exchanges successfully maintain a young adult patient with Crigler-Najjar syndrome type I. J Clin Apher 1989; 5:17.
- Van Der Veere CN, Schoemaker B, Bakker C, et al. Influence of dietary calcium phosphate on the disposition of bilirubin in rats with unconjugated hyperbilirubinemia. Hepatology 1996; 24:620.
- Van der Veere CN, Jansen PL, Sinaasappel M, et al. Oral calcium phosphate: a new therapy for Crigler-Najjar disease? Gastroenterology 1997; 112:455.
- Hafkamp AM, Havinga R, Sinaasappel M, Verkade HJ. Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats. Hepatology 2005; 41:526.
- Nishioka T, Hafkamp AM, Havinga R, et al. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats. J Pediatr 2003; 143:327.
- Hafkamp AM, Nelisse-Haak R, Sinaasappel M, et al. Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial. Pediatr Res 2007; 62:725.
- Valaes T, Petmezaki S, Henschke C, et al. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 1994; 93:1.
- Kappas A, Drummond GS, Henschke C, Valaes T. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics 1995; 95:468.
- Vroemen JP, Blanckaert N, Buurman WA, et al. Treatment of enzyme deficiency by hepatocyte transplantation in rats. J Surg Res 1985; 39:267.
- Ilan Y, Roy-Chowdhury N, Prakash R, et al. Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobes. Transplantation 1997; 64:8.
- Demetriou AA, Whiting JF, Feldman D, et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986; 233:1190.
- Guha C, Parashar B, Deb NJ, et al. Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 2002; 36:354.
- Gupta S, Aragona E, Vemuru RP, et al. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 1991; 14:144.
- Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338:1422.
- Ambrosino G, Varotto S, Strom SC, et al. Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 2005; 14:151.
- Tada K, Roy-Chowdhury N, Prasad V, et al. Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. Cell Transplant 1998; 7:607.
- Jia Z, Dankó I. Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle. Mol Ther 2005; 12:860.
- Toietta G, Mane VP, Norona WS, et al. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A 2005; 102:3930.
- Parashar B, Ghosh S, Kadakol A, et al. Recombinant simian virus 40 vectors integrate into host genome, and permit efficient, long-term and repeatable gene transfer to the liver in vivo (abstract). Hepatology 1999; 30:298A.
- Sauter BV, Parashar B, Chowdhury NR, et al. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. Gastroenterology 2000; 119:1348.
- Wilson JM, Grossman M, Wu CH, et al. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J Biol Chem 1992; 267:963.
- Chowdhury NR, Wu CH, Wu GY, et al. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. J Biol Chem 1993; 268:11265.
- Bommineni VR, Chowdhury NR, Wu GY, et al. Depolymerization of hepatocellular microtubules after partial hepatectomy. J Biol Chem 1994; 269:25200.
- Kren BT, Bandyopadhyay P, Steer CJ. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 1998; 4:285.
- Kren BT, Parashar B, Bandyopadhyay P, et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci U S A 1999; 96:10349.
- ARIAS IM. Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. J Clin Invest 1962; 41:2233.
- Gordon ER, Shaffer EA, Sass-Kortsak A. Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II. Gastroenterology 1976; 70:761.
- Fevery J, Blanckaert N, Heirwegh KP, et al. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 1977; 60:970.
- Gollan JL, Huang SN, Billing B, Sherlock S. Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies. Gastroenterology 1975; 68:1543.
- Gabilan JC, Benattar C, Lindenbaum A. Clofibrate treatment of neonatal jaundice. Pediatrics 1990; 86:647.
- Passuello V, Puhl AG, Wirth S, et al. Pregnancy outcome in maternal Crigler-Najjar syndrome type II: a case report and systematic review of the literature. Fetal Diagn Ther 2009; 26:121.
- TYPE I DISEASE
- Molecular defect
- Clinical manifestations and diagnosis
- - Distinction from type II disease
- - Phototherapy
- - Plasmapheresis
- - Calcium phosphate supplementation
- - Orlistat
- - Inhibition of bilirubin production
- - Liver transplantation
- - Hepatocyte transplantation
- Gene therapy
- - Ex vivo gene transduction
- - Vector-mediated gene delivery
- - Adenoviral vectors
- - SV40 and lentiviruses
- - Receptor-mediated gene delivery to the liver
- - Site-directed gene conversion
- TYPE II DISEASE
- Molecular defect
- SUMMARY AND RECOMMENDATIONS